Schizophrenia and its related conditions are all too common among young adults and are prevalent in about 1% of the general population. This is a devastating disorder of thinking; if gone undetected and thus untreated it can lead to robbing an individual of his or her life’s goals and aspirations as it develops. If unchecked, it can lead to either suicidal or violent behavior towards others because the affected individual may become plagued by increasing paranoia, bothersome auditory hallucinations commanding various actions, and a general withdrawal from reality. Lately some unfortunate cases of developing schizophrenia have made the news because of the tragic and deadly events they initiated. These have spurred controversial gun control debates and have brought mental illness to the forefront of these debates about government legislation nationally.
Currently, however, we do have the availability of many medications that if administered early to people developing these symptoms, can lead to recovery and the maintenance of a good quality of life. Doctors and other clinicians who initially see these individuals need to know which of these medications would be helpful and how to use them. There are also many new research findings that examine the brain and genetic make-up of people who develop schizophrenia. These can ultimately lead to new and better treatments and preventive measures.
When a family member has schizophrenia, often a parent does not know whom to turn. 100 Questions and Answers about Schizophrenia, Third Edition provides guidance and understanding about the illness and is a resource for letting family members and individuals suffering from the disease to know where they can go for help and support. It is also a guide for clinicians in the community and other healthcare providers who do not see these patients on an everyday basis and thus may miss the signs and symptoms.
Post written by Lynn E. DeLisi, MD. Dr. DeLisi is the author of 100 Questions & Answers About Schizophrenia and is a professor of psychiatry at New York University and associate director of the Center for Advanced Brain Imaging at The Nathan S. Kline Institute for Psychiatric Research. She is international editor-in-chief of the journal, Schizophrenia Research, and a member of the editorial board of several journals. She has co-authored over 250 scientific publications and has edited or written other scientific books.